Market Summery
Acknowledging the impressive growth records, the market perceives
currently, Market Research Future (MRFR) in its recently published study report
asserts that the global Capillary Blood
Collection Devices market size will
register a staggering CAGR of 6.2% from 2022-2030, witnessing the accruals of
approx. 790 Mn. USD by 2030.
The Capillary Blood Collection Devices Market has witnessed
significant growth in recent years, driven by the increasing prevalence of
chronic diseases and the growing demand for minimally invasive diagnostic
procedures. Among the various devices in this market segment, capillary blood
collection tubes play a pivotal role in the collection, storage, and
transportation of blood samples. These tubes are designed to facilitate the
collection of small blood volumes from capillaries, typically from a finger prick,
making them particularly useful in settings where venous blood collection is
challenging or impractical.
The demand for capillary blood
collection tubes is fueled by their
convenience, accuracy, and efficiency in point-of-care testing and remote
healthcare settings. With advancements in technology, manufacturers are
focusing on developing capillary blood collection tubes with improved features
such as better compatibility with various analyzers, enhanced sample stability,
and reduced risk of hemolysis. Additionally, the market is witnessing a surge
in the adoption of capillary blood collection tubes in applications such as
glucose monitoring, hemoglobin testing, and lipid profiling, further driving
market growth. As healthcare systems continue to prioritize decentralized
testing and remote patient monitoring, the Capillary Blood Collection Devices
Market is expected to expand, with capillary blood collection tubes playing a
crucial role in facilitating decentralized diagnostic testing and improving
healthcare accessibility and efficiency.
Competitive Landscape of Capillary Blood Collection Devices
Market:
The global market for capillary blood collection devices is
characterized by intense competition and diversification, with major
manufacturers operating on a global scale. These players are heavily investing
in research and development, global expansion, advanced technologies, and
product launches to gain a competitive edge in the market.
Key Players:
The market for capillary blood
collection devices companies includes
such as Danaher Corporation, Abbott Laboratories, F. Hoffmann-La Roche AG,
Becton Dickinson and Company, Medtronic Plc., Novo Nordisk A S, Thermo Fisher
Scientific Inc., Terumo Corporation, B. Braun Melsungen AG, HTL-STREFA S.A.,
Sarstedt AG & Co, Ypsomed Holding AG, Greiner Bio-One, Owen Mumford Ltd.,
Improve Medical, Nipro, Chengdu Rich Science Industry Co., Ltd., Weigao Group,
Weihai Hongyu Medical Devices, and Medigard. MRFR has profiled these players
and analyzed their strategies for maintaining a competitive position in the
market.
Segments of Capillary Blood Collection Devices Market:
The analysis by MRFR is segmented into four key areas to
facilitate the report and improve comprehension:
Materials: Including Glass, Plastic, and Stainless Steel, among
others. Types of Devices: Encompassing Warming Devices, Blood Collecting Tubes
& Collectors, and Lancets, among others. End-Users: Such as Hospitals,
Clinics, Diagnostic Centers, Home Diagnostics, and Pathology Laboratories,
among others. Regions: Covering North America, Europe, APAC, and
Rest-of-the-World. Plastic is projected to dominate the materials segment,
acquiring 42.3% of the market share, making it the largest share. This segment
is expected to register a 10.4% CAGR during the period of 2017–2023.
The Blood Collecting Tubes and Collector segment is anticipated to
hold the largest share based on types of devices, accounting for 48.4% of the
market share over the review period.
The Lancets Segment is projected to grow at a CAGR of 10.4%
between 2017–2023.
Regional Analysis of Capillary Blood Collection Devices Market:
North America leads the global capillary blood collection devices
market, supported by established players and investments, holding the largest
market share. Companies manufacturing these devices can provide customized
solutions, and the region sees increased uptake of software solutions for
healthcare administration, driving market growth.
Factors contributing to market growth include a rising number of
patients with chronic diseases, demand for technologically advanced diagnosis
and treatment, government support, and high per capita healthcare expenditures,
with the market estimated to reach US$ 292.96 million by 2023.
Europe is the second-largest market for capillary blood collection
devices globally, driven by technological advancements and increased adoption
among healthcare providers, particularly in the UK, Germany, and France.
Factors such as public and private funding for research and development,
leading market players, and the prevalence of diabetes are expected to fuel
market growth.
The Asia Pacific market is emerging as a promising market for
capillary blood collection devices, driven by new diagnosis and treatment
methods, increasing prevalence of chronic diseases like diabetes, and growing
awareness about health management among the population. The APAC market is
estimated to grow at a CAGR of 10.6% during 2017–2023.
The Middle East & Africa region is expected to experience a
plateau in growth due to factors such as limited awareness, access, and
availability of treatment facilities in the African market. However, the Middle
East is expected to see steady growth due to its well-developed healthcare
sector, particularly in countries like the UAE.
Related Reports-
